Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2022-07-08
4:57 pm
Sale
13GLineage Cell Therapeutics, Inc.
LCTX
BlackRock Inc.
BLK
3,755,757
2.2%
-6,252,753decrease
(-62.47%)
View
2022-03-25
5:23 pm
Purchase
13DLineage Cell Therapeutics, Inc.
LCTX
BROADWOOD PARTNERS L.P.35,227,273
20.7%
980,106increase
(+2.86%)
View
2022-02-04
4:12 pm
Purchase
13GLineage Cell Therapeutics, Inc.
LCTX
BlackRock Inc.
BLK
10,008,510
5.9%
10,008,510increase
(New Position)
View
2021-03-16
5:04 pm
Purchase
13DLineage Cell Therapeutics, Inc.
LCTX
BROADWOOD PARTNERS L.P.34,247,167
21.2%
335,268increase
(+0.99%)
View
2021-01-08
5:00 pm
Sale
13DOncoCyte Corporation
OCX
Lineage Cell Therapeutics Inc.
LCTX
3,297,401
4.9%
-968,503decrease
(-22.70%)
View
2020-04-27
5:28 pm
Sale
13DOncoCyte Corporation
OCX
Lineage Cell Therapeutics Inc.
LCTX
4,265,904
6.3%
-1,775,250decrease
(-29.39%)
View
2020-02-14
4:45 pm
Purchase
13DLineage Cell Therapeutics Inc.
BTX
GREENBELT CORP5,697,875
3.62%
5,697,875increase
(New Position)
View
2020-01-06
5:00 pm
Sale
13DOncoCyte Corporation
OCX
Lineage Cell Therapeutics Inc.
LCTX
6,041,154
10%
-2,383,090decrease
(-28.29%)
View
2019-09-13
5:18 pm
Sale
13DOncoCyte Corporation
OCX
Lineage Cell Therapeutics Inc.
LCTX
8,424,244
16.2%
-4,000,000decrease
(-32.20%)
View
2019-07-05
4:30 pm
Sale
13DOncoCyte Corporation
OCX
Lineage Cell Therapeutics Inc.
LCTX
12,424,244
23.9%
-2,250,000decrease
(-15.33%)
View
2019-03-12
5:02 pm
Purchase
13DLineage Cell Therapeutics Inc.
BTX
BROADWOOD PARTNERS L.P.33,911,899
22.4%
6,579,737increase
(+24.07%)
View
2019-03-11
7:07 pm
Sale
13DAsterias Biotherapeutics Inc.
AST
Lineage Cell Therapeutics Inc.
LCTX
0
0%
-21,747,569decrease
(Position Closed)
View
2018-11-08
5:13 pm
Unchanged
13DAsterias Biotherapeutics Inc.
AST
Lineage Cell Therapeutics Inc.
LCTX
21,747,569
39.2%
0
(Unchanged)
View
2018-08-21
9:47 pm
Unchanged
13DOncoCyte Corporation
OCX
Lineage Cell Therapeutics Inc.
LCTX
14,674,244
36.1%
0
(Unchanged)
View
2018-05-18
4:10 pm
Unchanged
13DOncoCyte Corporation
OCX
Lineage Cell Therapeutics Inc.
LCTX
14,674,244
37.2%
0
(Unchanged)
View
2018-04-03
4:24 pm
Unchanged
13DOncoCyte Corporation
OCX
Lineage Cell Therapeutics Inc.
LCTX
14,674,244
38.8%
0
(Unchanged)
View